Literature DB >> 18322038

Human RNA "rumor" viruses: the search for novel human retroviruses in chronic disease.

Cécile Voisset1, Robin A Weiss, David J Griffiths.   

Abstract

Retroviruses are an important group of pathogens that cause a variety of diseases in humans and animals. Four human retroviruses are currently known, including human immunodeficiency virus type 1, which causes AIDS, and human T-lymphotropic virus type 1, which causes cancer and inflammatory disease. For many years, there have been sporadic reports of additional human retroviral infections, particularly in cancer and other chronic diseases. Unfortunately, many of these putative viruses remain unproven and controversial, and some retrovirologists have dismissed them as merely "human rumor viruses." Work in this field was last reviewed in depth in 1984, and since then, the molecular techniques available for identifying and characterizing retroviruses have improved enormously in sensitivity. The advent of PCR in particular has dramatically enhanced our ability to detect novel viral sequences in human tissues. However, DNA amplification techniques have also increased the potential for false-positive detection due to contamination. In addition, the presence of many families of human endogenous retroviruses (HERVs) within our DNA can obstruct attempts to identify and validate novel human retroviruses. Here, we aim to bring together the data on "novel" retroviral infections in humans by critically examining the evidence for those putative viruses that have been linked with disease and the likelihood that they represent genuine human infections. We provide a background to the field and a discussion of potential confounding factors along with some technical guidelines. In addition, some of the difficulties associated with obtaining formal proof of causation for common or ubiquitous agents such as HERVs are discussed.

Entities:  

Mesh:

Year:  2008        PMID: 18322038      PMCID: PMC2268285          DOI: 10.1128/MMBR.00033-07

Source DB:  PubMed          Journal:  Microbiol Mol Biol Rev        ISSN: 1092-2172            Impact factor:   13.044


  525 in total

Review 1.  Role of endogenous retroviruses in autoimmune diseases.

Authors:  Ines Colmegna; Robert F Garry
Journal:  Infect Dis Clin North Am       Date:  2006-12       Impact factor: 5.982

2.  Consensus-degenerate hybrid oligonucleotide primers for amplification of distantly related sequences.

Authors:  T M Rose; E R Schultz; J G Henikoff; S Pietrokovski; C M McCallum; S Henikoff
Journal:  Nucleic Acids Res       Date:  1998-04-01       Impact factor: 16.971

3.  Possible diagnostic implications of a mammary tumor virus related protein in human breast cancer.

Authors:  S Spiegelman; I Keydar; R Mesa-Tejada; T Ohno; M Ramanarayanan; R Nayak; J Bausch; C Fenoglio
Journal:  Cancer       Date:  1980-08-15       Impact factor: 6.860

4.  The use of primers from highly conserved pol regions to identify uncharacterized retroviruses by the polymerase chain reaction.

Authors:  L A Donehower; R C Bohannon; R J Ford; R A Gibbs
Journal:  J Virol Methods       Date:  1990-04       Impact factor: 2.014

5.  Sheep retrovirus structural protein induces lung tumours.

Authors:  Sarah K Wootton; Christine L Halbert; A Dusty Miller
Journal:  Nature       Date:  2005-04-14       Impact factor: 49.962

6.  Lack of BLV and PTLV DNA sequences in the majority of patients with large granular lymphocyte leukaemia.

Authors:  R N Perzova; T P Loughran; S Dube; J Ferrer; E Esteban; B J Poiesz
Journal:  Br J Haematol       Date:  2000-04       Impact factor: 6.998

7.  Evidence for a protein related immunologically to the jaagsiekte sheep retrovirus in some human lung tumours.

Authors:  M De las Heras; S H Barsky; P Hasleton; M Wagner; E Larson; J Egan; A Ortin; J A Gimenez-Mas; M Palmarini; J M Sharp
Journal:  Eur Respir J       Date:  2000-08       Impact factor: 16.671

8.  Antibody reacting with the murine mammary tumor virus in the serum of patients with breast carcinoma: a possible serological detection method for breast carcinoma.

Authors:  W D Holder; S A Wells
Journal:  Cancer Res       Date:  1983-01       Impact factor: 12.701

Review 9.  Unexplained opportunistic infections and CD4+ T-lymphocytopenia without HIV infection. An investigation of cases in the United States. The Centers for Disease Control Idiopathic CD4+ T-lymphocytopenia Task Force.

Authors:  D K Smith; J J Neal; S D Holmberg
Journal:  N Engl J Med       Date:  1993-02-11       Impact factor: 91.245

10.  Autoimmune disease in mice due to integration of an endogenous retrovirus in an apoptosis gene.

Authors:  J Wu; T Zhou; J He; J D Mountz
Journal:  J Exp Med       Date:  1993-08-01       Impact factor: 14.307

View more
  79 in total

1.  A cautionary tale of virus and disease.

Authors:  Robin A Weiss
Journal:  BMC Biol       Date:  2010-09-27       Impact factor: 7.431

2.  Analysis of single-nucleotide polymorphisms in patient-derived retrovirus integration sites reveals contamination from cell lines acutely infected by xenotropic murine leukemia virus-related virus.

Authors:  Alice Rusmevichientong; Jaydip Das Gupta; Petra S Elias; Robert H Silverman; Samson A Chow
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

3.  Patients, patience, and the publication process.

Authors:  Randy Schekman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-23       Impact factor: 11.205

4.  Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences.

Authors:  Leonora Balaj; Ryan Lessard; Lixin Dai; Yoon-Jae Cho; Scott L Pomeroy; Xandra O Breakefield; Johan Skog
Journal:  Nat Commun       Date:  2011-02-01       Impact factor: 14.919

Review 5.  Studies of endogenous retroviruses reveal a continuing evolutionary saga.

Authors:  Jonathan P Stoye
Journal:  Nat Rev Microbiol       Date:  2012-05-08       Impact factor: 60.633

6.  Paleovirology: inferring viral evolution from host genome sequence data.

Authors:  Aris Katzourakis
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-08-12       Impact factor: 6.237

7.  Randomized clinical trial: Combination antiretroviral therapy with tenofovir-emtricitabine and lopinavir-ritonavir in patients with primary biliary cholangitis.

Authors:  Ellina Lytvyak; Ishwar Hosamani; Aldo J Montano-Loza; Lynora Saxinger; Andrew L Mason
Journal:  Can Liver J       Date:  2019-01-09

Review 8.  Xenotropic Murine Leukemia Virus-Related Virus (XMRV) and the Safety of the Blood Supply.

Authors:  Andrew D Johnson; Claudia S Cohn
Journal:  Clin Microbiol Rev       Date:  2016-10       Impact factor: 26.132

9.  Mouse mammary tumor virus in human breast cancer red herring or smoking gun?

Authors:  Andrew L Mason; Susanna Y Gilady; John R Mackey
Journal:  Am J Pathol       Date:  2011-08-30       Impact factor: 4.307

10.  Detection of a gammaretrovirus, XMRV, in the human population: open questions and implications for xenotransplantation.

Authors:  Joachim Denner
Journal:  Retrovirology       Date:  2010-03-10       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.